Rankings
▼
Calendar
BCYC FY 2023 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$374M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$27M
+86.5% YoY
Gross Profit
-$130M
-480.1% margin
Operating Income
-$190M
-704.1% margin
Net Income
-$181M
-669.7% margin
EPS (Diluted)
$-5.08
Cash Flow
Operating Cash Flow
-$61M
Free Cash Flow
-$64M
Stock-Based Comp.
$32M
Balance Sheet
Total Assets
$595M
Total Liabilities
$224M
Stockholders' Equity
$371M
Cash & Equivalents
$526M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$27M
$14M
+86.5%
Gross Profit
-$130M
$14M
-995.5%
Operating Income
-$190M
-$117M
-62.8%
Net Income
-$181M
-$113M
-60.3%
← Q4 2022
All Quarters
Q1 2023 →